ZDHHC16 expression was significantly positive associated with clinicopathological stage, tumor grade and ICB immunotherapy key genes (i.e., CD274, CTLA4, HAVCR2 and PDCD1, etc.). The gene discussed is PDCD1; the disease is neoplasm.